28 citations
,
December 2017 in “Journal of Investigative Dermatology Symposium Proceedings” Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.
6 citations
,
May 2013 in “Journal of Clinical Oncology” Combining Ficlatuzumab and Gefitinib can cause severe hair loss.
March 2012 in “Society for Endocrinology BES 2012” A new method was developed to analyze certain hormones and drugs in human blood efficiently.
1 citations
,
April 2025 in “Skin Health and Disease” The DREAM TO TREAT AD study is a pan-European register-based observational study designed to evaluate the effectiveness and safety of abrocitinib compared to conventional systemic therapies in patients with moderate to severe atopic dermatitis. The study utilizes real-world data from multiple European countries to provide insights into treatment outcomes. The primary objective is to assess the long-term safety and efficacy of abrocitinib, a Janus kinase inhibitor, in a diverse patient population. This study aims to fill the gap in knowledge regarding the real-world application of abrocitinib and its comparison with existing therapies, contributing valuable information for clinical decision-making in the management of atopic dermatitis.
July 2019 in “International journal of Unani and integrative medicine” Aftimoon (Cuscuta reflexa) has various health benefits, including anti-inflammatory and anticonvulsant effects.
July 2023 in “The journal of sexual medicine” Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.
2 citations
,
August 2016 February 2026 in “Journal of Psychosexual Health” Finasteride can cause long-lasting sexual dysfunction even after stopping the drug.
2 citations
,
January 2015 in “Journal of Investigative Dermatology” 34 citations
,
July 1993 in “PubMed”
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The N-K GM Series offers a free, effective solution to eliminate aflatoxin and cancer, improving health and life expectancy.
September 2010 in “European Urology Supplements”
January 2024 in “Hair transplant forum international” I'm sorry, but I can't provide a summary without the content of the document.
September 2023 in “Hair transplant forum international” I'm sorry, but I can't provide a summary without the content of the document.
July 2023 in “Hair transplant forum international” I'm sorry, but I can't provide a summary without the content of the document.
16 citations
,
July 1996 in “Journal of Investigative Dermatology”
January 2021 in “Hair transplant forum international” The ABHRS exam will be available online in 2021.
72 citations
,
June 1979 in “Biochemical Society Transactions” Flutamide and its metabolite can effectively reduce androgen effects.
August 2016 in “Journal of Investigative Dermatology”
January 2021 in “Hair transplant forum international” The document's content could not be processed.
August 2015 in “Dermatología Argentina” Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.
2 citations
,
June 2019 in “Boletín médico del Hospital Infantil de México” Tofacitinib treatment is used for teenagers with alopecia areata.
23 citations
,
June 2010 in “Journal of Investigative Dermatology” A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.
August 2004 in “Medisch-Farmaceutische Mededelingen” Long-term use of finasteride may cause breast cancer in men.
October 1993 in “Proceedings of The Nutrition Society”
November 2023 in “Indian Dermatology Online Journal” Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.
9 citations
,
March 2019 in “European Journal of Sport Science” New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.
May 2024 in “Clinical and experimental optometry”
1 citations
,
May 2024 in “Dermatology and Therapy” Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.